iShares US Pharmaceuticals ETF
IHE
IHE
87 hedge funds and large institutions have $197M invested in iShares US Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 39 reducing their positions, and 11 closing their positions.
Holders
87
Holders Change
-4
Holders Change %
-4.4%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
7
Increased
20
Reduced
39
Closed
11
Calls
$259K
Puts
–
Net Calls
+$259K
Net Calls Change
+$259K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$31M |
2 |
VF
2
Virtu Financial
New York
|
$2.79M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$2.65M |
4 |
AG
4
Advisor Group
Phoenix,
Arizona
|
$1.1M |
5 |
MFS
5
MSI Financial Services
Springfield,
Massachusetts
|
$5.95M |